Freenome
PrivateLast Round
Corporate Funding
11/18/2025
Total Funding Raised
$1.2B
Momentum Score
25 /100
Company Overview
Freenome is a healthcare technology company that offers a multi-omics platform for early cancer detection through routine blood tests, utilizing a proprietary algorithm to enhance disease management via systematic early screening and intervention.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical AI, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Freenome Comps
Public and private peers based on sector, stage, and business model.
Freenome Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | 11/18/2025 | ||||
| VC Round | 2/15/2024 | ||||
| Series D Extension | 1/11/2022 | ||||
| Series D | 12/7/2021 | ||||
| Series C | 8/26/2020 | ||||
Series B | 7/24/2019 |
Freenome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EcoR1 Capital | Series C |
| The House Fund | Series A |
| Andreessen Horowitz | Series B, Series C, Series A, Seed |
| S32 | VC Round, Series B, Series D, Series C |
| Soleus Capital | Series C |
| Bain Capital Life Sciences | VC Round, Series D, Series D Extension, Series C |
| Janus Henderson Group | Series D, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 31, 2026
Pursuing regulated development for multiomics cancer screening tests.
- Jan 1, 2026
Job postings suggest readiness for IPO and public company reporting.
Freenome Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Freenome's valuation, stock price, and market status.
